Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT04828759
Eligibility Criteria:
Inclusion Criteria:
* Post-stroke aphasia ≥ 3 months from stroke
* Age 18-75 years
* Finnish as a native language
* Relative have the motivation and willingness to support person with aphasia in rehabilitation process
* At least some level of spoken output
* Moderate-to-severe aphasia
* Deficit in a word retrieval process
Exclusion Criteria:
* Participation in other intervention study during the study
* Participation in other traditional speech and language therapy during the VR-intervention (i.e. 9-10 weeks period).
* Severe and current psychotic disorder
* Dementia/other neurodegenerative disease
* History of previous stroke (/strokes) if not recovered, excluding TIAs (the criteria for the recovery: no residual aphasia or other disabilities caused by stroke which would affect in significant manner on everyday life)
* Active epilepsy / migraine (\< 3 years)
* Severe apraxia of speech
* Inability to act according to given instruction
* Severe neuropsychological disorder or the decline of cognitive / memory functions, which would significantly affect for training during the VR-intervention
* Vision or hearing impairment which would prevent the use of VR HMD
* if the participant's treatment or medication is unsuitable with the use of VR HMD device as assessed by the physician
* if the participant has the pacemaker or implantable (electric) medical device
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04828759
Study Brief:
Protocol Section:
NCT04828759